Robert Pignolo

26PUBLICATIONS
82CO-AUTHORS
Flight dynamicsMolecular targetsRadiation therapyDisease surveillanceAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 22, 2026
Palovarotene impact on fibrodysplasia ossificans progressiva (FOP): data from month 48 of the phase III MOVE trial.

|Sep 15, 2026
BCX9250 is a potent small-molecule inhibitor of Activin A Receptor Type 1 (ACVR1/ALK2) for fibrodysplasia ossificans progressiva.

|Aug 08, 2026
Suppression of early pro-inflammatory senescent signature post-radiotherapy mitigates chronic bone damage.

|Jul 22, 2026
Incidence of RSV-Acute Respiratory Infection in Adults 18-64 Years With High-Risk Conditions: A Prospective Community-based Surveillance Study.

|Mar 23, 2026
Suppression of early pro-inflammatory senescent signature post-radiotherapy mitigates chronic bone damage.

David Achudhan, Jacob Orme, Ritika Sharma

|Feb 05, 2026
Scoliosis in Fibrodysplasia Ossificans Progressiva: A Report of 4 Cases.

Zaid Elsabbagh, Myung-Jin Cha, Robert J Pignolo

Pageof 5

Frequent Collaborators

8 joint publications

Sundeep Khosla

7 joint publications

Abhishek Chandra

5 joint publications

David G Monroe

4 joint publications

Joshua N Farr